| Title |
Year |
Author |
Number |
| DERIVATIVES OF PYRROLO[2,3-D]PYRIMIDINES, PHARMACEUTICAL COMPOSITION, PYRROLO[2,3-D]PYRIMIDINES, DERIVATIVES OF PYRROLE |
1993 |
|
RU2124015C1 |
| 4-HETEROCYCLYL-SUBSTITUTED DERIVATIVE OF QUINAZOLINE, PHARMACEUTICAL COMPOSITION |
1995 |
|
RU2137762C1 |
| STIMULATING AGENTS OF GROWTH HORMONE SECRETION |
1996 |
- Filip A. Karpino
- Pol A. Dasil'Va Dzhardin
- Brjus A. Lefker
- Dzhon A. Rehgehn
|
RU2172742C2 |
| POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M4 |
2017 |
- Lindsli, Krejg V.
- Konn, P. Dzheffri
- Engers, Darren V.
- Bollinger, Shon
- Tarr, Dzhejms S.
- Spiaring, Pol
- Engers, Dzhuli L.
- Long, Madelin
- Bridzhes, Tomas M.
|
RU2750935C2 |
| PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1993 |
|
RU2124016C1 |
| SUBSTITUTED N-(INDOLE-2-CARBONYL)-BETA-ALANYLAMIDES AND THEIR DERIVATIVES, METHOD OF TREATING GLYCOGENPHOSPHORYLAZO-DEPENDENT DISEASES, METHOD FOR PREVENTING ISCHEMIC MYOCARDIUM DAMAGES, AND PHARMACEUTICAL COMPOSITIONS |
1996 |
- Bernard Kh'Julin
- Judit Li Tredvej
- Vill'Jam Kholt Martin
- Dennis Dzhej Khuver
|
RU2159613C2 |
| CORTICOTROPIN-RELEASING FACTOR ANTAGONISTS |
1995 |
|
RU2221799C2 |
| PYRROLIDINYL DERIVATIVES OF HYDROXAMIC ACID, METHOD OF PREPARATION THEREOF, INTERMEDIATES, METHOD OF PREPARATION THEREOF (VERSIONS), METHOD OF TREATMENT |
1996 |
|
RU2144917C1 |
| AMIDES, PHARMACEUTICAL COMPOSITION, METHODS OF DECREASE OF APOLIPOPROTEIN B SECRETION, COMPOUND |
1996 |
- Dzhorzh Chang
- Piter Kh.Dorff
- Dzhorzh Dzh.Kvollich
|
RU2141478C1 |
| SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINEAMIDES AND THEIR DERIVATIVES, METHODS OF TREATMENT OF PATIENTS AND PHARMACEUTICAL COMPOSITION |
1996 |
- Bernard Khalin
- Dzhudit Li Tridvej
- Vill'Jam Kholt Martin
- Dennis Dzhej Khuver
- Duglas Fillips
|
RU2143424C1 |
(I) and their stereoisomers and pharmaceutically acceptable salts where Y is 
; Z is NR1R2; R1 is hydrogen; R2 phenyl substituted by group (R5)m or Q, or R1R2N is group A: 
(A) (other designations see in claim 1) can be used in treatment of hyperproliferative conditions such as malignant tumors, psoriasis, renal diseases, and pancreatitis. EFFECT: extended choice of antiproliferative drugs. 12 cl, 3 dwg, 78 ex